Estimated study completion date

• platters
• Tuesday, July 25, 2023 7:11:11 PM
• 19 Comments

	File size: 2755 kB
	Views: 3284
	Downloads: 70
	Download links:
	Mirror link

Actual Study Start Date : September 7, 2020. Actual Primary Completion Date : January 22, 2021. Estimated Study Completion Date : January 2, 2023.The Primary Completion Date is the date that the final study participant was examined or received an intervention for the purpose of the final collection of.The Primary Completion Date is the date of the last study visit where data was collected for the primary study outcome(s). This will be the same.The estimated primary completion date is the date that the researchers think will be the primary completion date for the study.Actual Study Start Date : May 15, 2021. Estimated Primary Completion Date : March 31, 2023. Estimated Study Completion Date : March 31, 2023.Glossary of Common Site Terms - ClinicalTrials.govFrequently Asked Questions - ClinicalTrials.govA Study of Ad26.COV2.S for the Prevention of. - Clinical Trials

Estimated Study Completion Date : May 15, 2022. Expected compliance with protocol procedures and availability for clinical follow-up through the last.Study Type : Interventional (Clinical Trial). Estimated Enrollment : 13275 participants. Estimated Study Completion Date : June 12, 2023.Study Type : Interventional (Clinical Trial). Estimated Enrollment : 33000 participants. Estimated Study Completion Date : June 30, 2023.Estimated Study Completion Date : February 2022. COVID-19 two weeks after first dose of vaccine, regardless the vaccination schedule was completed.. Study Start Date : November 16, 2020. Estimated Primary Completion Date : May 10, 2022. Estimated Study Completion Date : May 31, 2023.Pfizer-BioNTech COVID-19 BNT162b2 Vaccine Effectiveness.Tip of the Week - Primary Completion Dates and Study.Clinical Trial of Efficacy and Safety of Sinovacands Adsorbed.. juhD453gf

Estimated Study Start Date : February 1, 2021. Estimated Primary Completion Date : March 22, 2023. Estimated Study Completion Date.Estimated Study Completion Date : November 30, 2021. humoral immune responses of BBV154 [ Time Frame: Through study completion, an average of 6 months ].Estimated Study Completion Date : March 16, 2023. Immune response measured after completion of a 2-dose immunization schedule, as determined by the.Actual Study Start Date : November 28, 2020. Estimated Primary Completion Date : January 28, 2023. Estimated Study Completion Date : January 28, 2023.Estimated Study Completion Date : September 20, 2022. clinical conditions that pose a risk for participation or completion of the study,.Estimated Study Start Date : December 2021. Estimated Primary Completion Date : March 2022. Estimated Study Completion Date : August 2022.Actual Study Start Date : March 15, 2021. Estimated Primary Completion Date : October 30, 2021. Estimated Study Completion Date : April 30, 2022.Recruitment Status : Active, not recruiting. Estimated Primary Completion Date : October 27, 2022. Estimated Study Completion Date : October 27, 2022.The estimated primary completion date is the date that the researchers think will be the primary completion date for the study. In a clinical studys.Estimated Study Completion Date : December 31, 2022. [ Time Frame: Day 0 to 6 months after completion of 3 doses vaccination. ].Estimated Study Completion Date : April 25, 2022. Has received or is expected to receive any COVID-19 vaccine, except for participants with an underlying.Study Type : Interventional (Clinical Trial). Estimated Enrollment : 21046 participants. Estimated Study Completion Date : April 13, 2023.Actual Study Start Date : September 15, 2020. Estimated Primary Completion Date : December 30, 2021. Estimated Study Completion Date : January 30, 2022.Estimated Study Completion Date : July 2022. vaccinations, laboratory tests, the electronic completion of the COVID-19 ePRO and other study procedures.Estimated Study Completion Date : December 18, 2022. and is not expected to receive chemotherapy within at least 2 weeks (14 days) after.Actual Study Start Date : May 20, 2021. Estimated Primary Completion Date : March 2023. Estimated Study Completion Date : April 2023.The estimated study completion date is the date that the researchers think will be the study completion date. The investigative methods and.Actual Study Start Date : November 3, 2017. Estimated Primary Completion Date : February 28, 2022. Estimated Study Completion Date : February 28, 2022.Study Type : Interventional (Clinical Trial). Estimated Enrollment : 72 participants. Estimated Study Completion Date : March 2023.This study is expected to enrol 40 participants (20 per study arm) at one study centre in. Estimated Study Completion Date : June 2022.Estimated Study Completion Date : November 28, 2025. Annualized flare rate will be calculated as the total number of flares divided by.Estimated Primary Completion Date : September 30, 2022. Estimated Study Completion Date : September 30, 2022.Estimated Study Start Date : October 2021. Estimated Primary Completion Date : October 2022. Estimated Study Completion Date : October 2023.Estimated Study Completion Date : April 23, 2022. Has received or is expected to receive any dose of a SARS-CoV-2 vaccine before the Day 34 visit.completion date as follows: IRB Approval Date + Expected Duration of Trial + 120 days. • Expected Duration of the Trial is determined from.Estimated Study Completion Date : August 24, 2022. GMR, estimated by the ratio of the geometric mean of SARS CoV 2 neutralizing titers in.Estimated Study Completion Date : August 19, 2024. Percent change in spot urinary oxalate:creatinine ratio was estimated by an average percent change.Actual Study Start Date : June 8, 2021. Estimated Primary Completion Date : December 2022. Estimated Study Completion Date : March 2023.We estimate that approximately 25,800 participants should be randomized to accrue these 130 events. Estimated Study Completion Date : December 2022.After 2 doses of vaccination of 1300 volunteers are completed, safety data will be. Estimated Study Completion Date : April 15, 2022.Actual Study Start Date : December 9, 2020. Estimated Primary Completion Date : April 28, 2023. Estimated Study Completion Date : April 28, 2023.Actual Study Start Date : December 6, 2021. Estimated Primary Completion Date : January 3, 2023. Estimated Study Completion Date : January 3.Estimated Study Completion Date : November 2022. is at a stage where it might interfere with trial conduct or completion.Actual Study Start Date : November 19, 2020. Estimated Primary Completion Date : December 31, 2021. Estimated Study Completion Date : April 30, 2022.Actual Study Start Date : April 23, 2020. Estimated Primary Completion Date : March 31, 2023. Estimated Study Completion Date : March 31, 2023.After completing a favorable 7-day safety observation following the first dose of 50μg. Estimated Study Completion Date : April 2023.Estimated Study Completion Date : July 13, 2023. GMR, estimated by the ratio of the GMTs of SARS-CoV-2 neutralizing titers at 1 month.Estimated Study Completion Date : August 7, 2022. 30 days prior to vaccination through 6 months after completion of the vaccine series.

• Clinical trial phases
• Common terms used in clinical trials
• Clinical study report submission timelines